Rani Therapeutics Holdings (RANI) Other Non Operating Income (2021)
Rani Therapeutics Holdings' (RANI) quarterly Other Non Operating Income came in at $1.4 million in Q4 2021, up 300.0% quarter-over-quarter from -$700000.0 in Q3 2021.
Rani Therapeutics Holdings (RANI) Other Non Operating Income (2021) Analysis & Trends
Rani Therapeutics Holdings' Other Non Operating Income history runs 1 years deep, the most recent figure standing at $1.4 million for Q4 2021.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to $1.4 million in Q4 2021; TTM through Dec 2022 was $700000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$576000.0, changed N/A from the prior year.
- Other Non Operating Income rose to $1.4 million in Q4 2021 per RANI's latest filing, from -$700000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.4 million in Q4 2021 and bottomed at -$700000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | -700,000.00 |